Powerae.com
What Is Glucagon-Like Peptide? An All-Inclusive Scientific Introduction
Few endogenous regulatory elements in metabolic science and biomedical research have been as widely investigated and recognized as Glucagon-Like Peptide, abbreviated as GLP. GLPs represent an important group of peptide hormones produced from the gut and contribute to the balanced blood glucose level, digestive metabolism, and energy management process. GLP was identified as a result of numerous studies that highlighted the role of the proglucagon gene in our organism, which revolutionized the way of understanding intestinal endocrine processes while turning GLP family of peptides into one of the major research areas in metabolic disorder treatment, endocrine control, and chronic disease investigation.
In order to understand GLP from the fundamental perspective, it is worth mentioning its origin and classification. The proglucagon gene is produced in a number of body organs, including pancreas, small intestines, and brain. Depending on the types of tissue where proglucagon is produced, a number of peptides with diverging nature can be obtained, and some of them are known as Glucagon-Like Peptide 1 (GLP-1) and Glucagon-Like Peptide 2 (GLP-2). The peptide is released from the intestines immediately after eating food and doesn’t accumulate in the body, as a “post-prandial regulator”.
It should be noted that the key characteristic of GLP is the mechanism of blood sugar regulation, known as the glucose-dependent insulinotropic effect.Unlike the traditional regulative agents that can trigger erratic changes in blood glucose levels, GLP works only when the glucose in the body is increased. After meals, when carbohydrates are absorbed to increase blood glucose levels, GLP is discharged quickly to stimulate the activity of pancreatic beta cells that secrete insulin and thus enhance glucose use by peripheral tissues like liver and muscles.
At the same time, GLP is capable of inhibiting glucagon secretion, which is the hormone that raises blood sugar, and thus causes two-way precise regulation of blood sugar. This particular functioning mechanism enables GLP to minimize the possibility of dangerous hypoglycemia, which makes it a very promising and effective metabolic regulator when it comes to theoretical research. Besides glucose metabolism control, GLP has a lot of benefits in regulating appetite and energy balance. With the help of blood circulation, GLP can act on the CNS to overcome excessive signals of hunger, bring down food intake, and slow down gastric emptying, thus providing a chance to improve the eating habits and maintaining metabolic balance in the body.
Apart from metabolism regulation, the number of preclinical laboratory research has disclosed that GLP has a possible multi-organ protective effect. For the digestive system, GLP-2 has the ability to recover intestinal barrier function, increase summation of intestinal cells, and improve microecological balance of intestines and, consequently, provide for development of many other research in the domain of intestinal injuries and malabsorption disease. For the cardiovascular system, GLP can facilitate the functioning of blood vessels, reduce oxidative stress, and inflammation in the blood vessels and thus provides protection against metabolic-related damage to blood vessels.
Zusätzlich, the new biomedical research studies continue reporting various functions of GLP. Numerous in vitro experiments and studies on animal models showed that GLP has a solid regulatory effect on lipid metabolism and can minimize the lipid build-up in the body, restore fat metabolism in the liver, and is worth researching in relation to obesity prevention and treatment. Zusätzlich, it was revealed that GLP may result in some neuroprotective effect and research in this area should be conducted as well.
It’s important to mention that GLP and its analogues seem to have convincing efficiency and prospects but many of their relevant experiments are still in laboratory stages of development, thus meaning that the long-term safety and maximum effective concentration of natural GLP peptides have not been checked out with humans yet.